首页> 外文期刊>Scientia pharmaceutica >Rapid Simultaneous Determination of Telmisartan, Amlodipine Besylate and Hydrochlorothiazide in a Combined Poly Pill Dosage Form by Stability-Indicating Ultra Performance Liquid Chromatography
【24h】

Rapid Simultaneous Determination of Telmisartan, Amlodipine Besylate and Hydrochlorothiazide in a Combined Poly Pill Dosage Form by Stability-Indicating Ultra Performance Liquid Chromatography

机译:稳定性指示超高效液相色谱法快速同时测定多药组合剂型中的替米沙坦,苯磺酸氨氯地平和氢氯噻嗪

获取原文
获取原文并翻译 | 示例
           

摘要

A simple, precise and rapid stability-indicating ultra-performance liquid chromatography (UPLC) method is developed for the simultaneous quantitative determination of Telmisartan, Amlodipine besylate and Hydrochlorothiazide from their innovative poly pill combination drug product in the presence of degradation products. It involves a 100 mm x 2.1 mm, 1.7 μm C-18 column. The separation is achieved on a simple gradient method. The mobile phase A contains a mixture of sodium perchlorate buffer pH 3.2 (0.053M): acetonitrile in the ratio 90:10, v/v, and mobile B contains a mixture of sodium perchlorate buffer pH 3.2 (0.053M): acetonitrile in the ratio 20:80, v/v. The flow rate is 0.6 mL min~(-1) and the column temperature is maintained at 55℃.The gradient program (T/%B) is set as 0/5, 1.2/5, 1.6/40, 4/40, 4.1/5 and 4.5/5. The detector wavelength is 271 nm for Hydrochlorothiazide and Telmisartan and 237 nm for Amlodipine. The retention times of Telmisartan, Amlodipine, and Hydrochlorothiazide are 3.6 minutes, 3.2 minutes and 0.9 minutes; respectively. The total runtime for the separation of the three active compounds and their degradation products is 4.5 minutes. The described method is validated with respect to system suitability, specificity, linearity, precision and accuracy. The precision of the assay method is evaluated by carrying out six independent assays of T, A and H (0.032 mg mL~(-1) of T, 0.004 mg mL~(-1) of A, 0.01 mg mL~(-1) of H). The accuracy of the method is evaluated in triplicate at three concentration levels, i.e. 50%, 100% and 150% of target test concentration (0.64 mg mL~(-1) of T, 0.08 mg mL~(-1) of A, 0.2 mg mL~(-1) of H). The described method is linear over the range, 16 to 48 μg mL~(-1) for T, 2 to 6 μg mL~(-1) A and 5 to 15 μg mL~(-1) for H. The method is fast and suitable for high-throughput analysis allowing the analysis of about 250 samples per working day.
机译:开发了一种简单,精确,快速的稳定性指示超高效液相色谱(UPLC)方法,用于在降解产物存在的情况下,从其创新的多药丸组合药物产品中同时定量测定替米沙坦,苯磺酸氨氯地平和氢氯噻嗪。它涉及100 mm x 2.1 mm,1.7μm的C-18色谱柱。分离是通过简单的梯度方法实现的。流动相A含有比例为90:10 v / v的高氯酸钠缓冲液pH 3.2(0.053M):乙腈的混合物,而流动相B则含有pH 3.2的高氯酸钠缓冲液(0.053M):乙腈的混合物比率20:80,v / v。流速为0.6 mL min〜(-1),柱温保持在55℃。将梯度程序(T /%B)设置为0 / 5、1.2 / 5、1.6 / 40、4 / 40, 4.1 / 5和4.5 / 5。氢氯噻嗪和替米沙坦的检测器波长为271 nm,氨氯地平的检测器波长为237 nm。替米沙坦,氨氯地平和氢氯噻嗪的保留时间分别为3.6分钟,3.2分钟和0.9分钟;分别。分离三种活性化合物及其降解产物的总运行时间为4.5分钟。相对于系统适用性,特异性,线性,精确度和准确性验证了所描述的方法。通过对T,A和H进行六次独立测定(0.032 mg mL〜(-1)的T,0.004 mg mL〜(-1)的A,0.01 mg mL〜(-1)的六种独立测定来评估测定方法的精度)的)。在三个浓度水平下,即目标测试浓度的50%,100%和150%(0.64 mg mL〜(-1)的T,0.08 mg mL〜(-1)的A, 0.2 mg mL〜(-1)的H)。所描述的方法在以下范围内呈线性:T范围为16至48μgmL〜(-1),A范围为2至6μgmL〜(-1),H范围为5至15μgmL〜(-1)。快速且适用于高通量分析,每个工作日可分析约250个样品。

著录项

  • 来源
    《Scientia pharmaceutica》 |2011年第1期|p.69-84|共16页
  • 作者单位

    Analytical Research and Development, Integrated Product Development, Dr. Reddy's Laboratories Ltd.,Bachupally, Hyderabad-500 072, India,Department of Chemistry, J.N.T. University, Kukatpally, Hyderabad-500 072, A.P., India;

    Analytical Research and Development, Integrated Product Development, Dr. Reddy's Laboratories Ltd.,Bachupally, Hyderabad-500 072, India;

    Analytical Research and Development, Integrated Product Development, Dr. Reddy's Laboratories Ltd.,Bachupally, Hyderabad-500 072, India;

    Analytical Research and Development, Integrated Product Development, Dr. Reddy's Laboratories Ltd.,Bachupally, Hyderabad-500 072, India;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Validation; Stability; UPLC; Simultaneous; Degradation; Method development;

    机译:验证;稳定性;UPLC;同时;降解;方法开发;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号